World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 119 340 312 11 11 572 58471
Medicine 120 3718 3481 144 140 596 59295

Jacques J.M. van Dongen publications per year

The chart shows the history of publications by Jacques J.M. van Dongen between 1974 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jacques J.M. van Dongen published across 52 years, from 1974 to 2025, averaging 12.8 papers a year. Output peaked at 31 publications in 2007. 27 of the 664 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1974 to 2025. Vertical axis: number of publications, 0 to 31. Peak 31 publications in 2007. 1974: 1 publication 1975: 1 publication 1976: 2 publications 1977: 1 publication 1978: 1 publication 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 1 publication 1983: 0 publications 1984: 7 publications 1985: 9 publications 1986: 7 publications 1987: 9 publications 1988: 11 publications 1989: 10 publications 1990: 6 publications 1991: 6 publications 1992: 2 publications 1993: 12 publications 1994: 7 publications 1995: 7 publications 1996: 5 publications 1997: 12 publications 1998: 15 publications 1999: 22 publications 2000: 15 publications 2001: 18 publications 2002: 20 publications 2003: 19 publications 2004: 23 publications 2005: 18 publications 2006: 25 publications 2007: 31 publications 2008: 19 publications 2009: 22 publications 2010: 24 publications 2011: 19 publications 2012: 22 publications 2013: 14 publications 2014: 20 publications 2015: 17 publications 2016: 21 publications 2017: 23 publications 2018: 17 publications 2019: 21 publications 2020: 13 publications 2021: 22 publications 2022: 19 publications 2023: 21 publications 2024: 15 publications 2025: 12 publications
1974 2025

664 publications in total across all disciplines

View publications per year as a table
Jacques J.M. van Dongen: publications per year, 1974 to 2025
Year Publications
1974 1
1975 1
1976 2
1977 1
1978 1
1979 0
1980 0
1981 0
1982 1
1983 0
1984 7
1985 9
1986 7
1987 9
1988 11
1989 10
1990 6
1991 6
1992 2
1993 12
1994 7
1995 7
1996 5
1997 12
1998 15
1999 22
2000 15
2001 18
2002 20
2003 19
2004 23
2005 18
2006 25
2007 31
2008 19
2009 22
2010 24
2011 19
2012 22
2013 14
2014 20
2015 17
2016 21
2017 23
2018 17
2019 21
2020 13
2021 22
2022 19
2023 21
2024 15
2025 12
Total 664
Download as CSV

Jacques J.M. van Dongen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jacques J.M. van Dongen sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 572–581 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 572 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17 572
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Jacques J.M. van Dongen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jacques J.M. van Dongen sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 118–119 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 119 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28 119
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Jacques J.M. van Dongen is affiliated with Leiden University Medical Center in the Netherlands, with a research focus primarily in Medicine and Immunology and Microbiology. Their work spans various subfields such as Immunology, Molecular Biology, Hematology, Genetics, and Oncology, highlighting a multidisciplinary approach to biomedical science.

The scientist's research covers several main topics, including:

  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • Immunodeficiency and Autoimmune Disorders
  • Lymphoma Diagnosis and Treatment
  • Single-cell and Spatial Transcriptomics
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia Research

Jacques J.M. van Dongen has contributed to multiple scientific papers across leading journals. Selected recent publications include:

  • Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19, 2021, published in Nature Immunology
  • Single-cell immune profiling reveals thymus-seeding populations, T cell commitment, and multilineage development in the human thymus, 2022, published in Science Immunology
  • Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID, 2020, published in Molecular Therapy - Methods & Clinical Development
  • Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube, 2020, published in Frontiers in Immunology
  • Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective, 2020, published in Frontiers in Immunology

The scientist collaborates extensively with fellow researchers, with frequent co-authors including Alberto Órfão, Cristina Teodósio, Vincent H. J. van der Velden, Magdalena A. Berkowska, and Martín Pérez-Andrés.

The venues where Jacques J.M. van Dongen most frequently publishes are:

  • Frontiers in Immunology
  • Cancers
  • bioRxiv (Cold Spring Harbor Laboratory)
  • HemaSphere
  • Blood

Best Publications

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

    J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans

  • Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

    J Gabert;E Beillard;V H J van der Velden;W Bi

  • Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

    van Dongen Jj;Macintyre Ea;Gabert Ja;Delabesse E

  • Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program

    E Beillard;N Pallisgaard;V H J van der Velden;W Bi

  • Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

    Jacques Jm van Dongen;Taku Seriu;E Renate Panzer-Grümayer;Andrea Biondi

  • EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

    J J M van Dongen;L Lhermitte;S Böttcher;J Almeida

  • Immunophenotyping of blood lymphocytes in childhood: Reference values for lymphocyte subpopulations

    W.Marieke Comans-Bitter;Ronald de Groot;René van den Beemd;Herman J. Neijens

  • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    Valentino Conter;Claus R. Bartram;Maria Grazia Valsecchi;Andre Schrauder

  • EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

    T Kalina;J Flores-Montero;V H J van der Velden;M Martin-Ayuso

  • Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

    V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock

  • Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

    V H J van der Velden;A Hochhaus;G Cazzaniga;T Szczepanski

  • Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    J Flores-Montero;L Sanoja-Flores;B Paiva;N Puig

  • An antibody-deficiency syndrome due to mutations in the CD19 gene

    Menno C van Zelm;Ismail Reisli;Mirjam van der Burg;Diana Castaño

  • Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

    Jacques J. M. van Dongen;Vincent H. J. van der Velden;Monika Brüggemann;Alberto Orfao

  • EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

    A. W. Langerak;P. J. T. A. Groenen;M. Brüggemann;K. Beldjord

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Martin Schrappe;Maria Grazia Valsecchi;Claus R. Bartram;André Schrauder

  • Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

    Richard A. Larson;Eric L. Sievers;Eric L. Sievers;Edward A. Stadtmauer;Bob Löwenberg

  • Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.

    T Flohr;T Flohr;A Schrauder;G Cazzaniga;R Panzer-Grümayer

  • New insights to the MLL recombinome of acute leukemias

    C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

  • Proposals for immunological classification of acute leukemias

    J. J. M. Van Dongen

Frequent Co-Authors

Alberto Orfao
Alberto Orfao University of Salamanca
Mirjam van der Burg
Mirjam van der Burg Erasmus University Rotterdam
Anton W. Langerak
Anton W. Langerak Erasmus University Rotterdam
Menno C. van Zelm
Menno C. van Zelm Monash University
Frank J.T. Staal
Frank J.T. Staal Leiden University Medical Center
Julia Almeida
Julia Almeida University of Salamanca
Dik C. van Gent
Dik C. van Gent Erasmus University Rotterdam
Arjan C. Lankester
Arjan C. Lankester Leiden University Medical Center
Herbert Hooijkaas
Herbert Hooijkaas Erasmus University Rotterdam
Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring immunology often opens doors to a variety of healthcare careers that blend science with patient care. For those interested in advancing clinical skills, programs such as accelerated FNP offer a fast track to becoming Family Nurse Practitioners, expanding opportunities in primary care and specialized immunological practice.

Students coming from non-nursing backgrounds can also transition smoothly into healthcare through online ABSN programs for non nurses. These programs provide essential nursing knowledge and training required to support immunology-related healthcare roles effectively.

For those seeking accessible nursing pathways, the easiest accelerated nursing programs to get into can be ideal starting points. They ensure quicker entry into nursing careers, often allowing students to later specialize, including in immunology and infectious disease care.

Moreover, programs labeled as easy LPN programs to get into serve as excellent entry-level options. Licensed Practical Nurses with immunology knowledge can support a variety of clinical and research settings, playing critical roles in patient education and immunization efforts.

Overall, these diverse educational pathways offer students interested in immunology flexible routes to professional growth within health sciences, balancing accessibility with specialized expertise.

Best Scientists Citing Jacques J.M. van Dongen

Trending Scientists

Recently Published Articles